10-Q Filing

Astrana Health, Inc. CIK: 1083446 Q3 2016

Filing Information

Form Type	10-Q
Accession Number	`0001144204-17-009037`
Period End Date	20161231
Filing Date	20170214
Fiscal Year	2016
Fiscal Period	Q3
XBRL Instance	ameh-20161231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 75 Income Statement 72 Cash Flow Statement 105

Balance Sheet 75 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, net of allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$601.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$762.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.27M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.64M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.99M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.01M	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $762,000 and $601,000 at December 31, 2016 and March 31, 2016, respectively	`AccountsReceivableNetCurrent`	$3.39M	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $762,000 and $601,000 at December 31, 2016 and March 31, 2016, respectively	`AccountsReceivableNetCurrent`	$5.99M	USD	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	$581.21K	USD	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	$313.51K	USD	Point-in-time
Due from affiliates	`DueFromAffiliateCurrent`	$20.50K	USD	Point-in-time
Due from affiliates	`DueFromAffiliateCurrent`	$18.31K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$293.83K	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$499.15K	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$10.81M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$13.56M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	6.03M	shares	Point-in-time
Deferred financing costs	`DeferredFinanceCostsNoncurrentNet`	-	USD	Point-in-time
Deferred financing costs	`DeferredFinanceCostsNoncurrentNet`	$37.93K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	5.88M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.25M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	5.88M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	6.03M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.30M	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$765.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$530.00K	USD	Point-in-time
Debt Instrument, Unamortized Discount, Current	`DebtInstrumentUnamortizedDiscountCurrent`	$5.73K	USD	Point-in-time
Debt Instrument, Unamortized Discount, Current	`DebtInstrumentUnamortizedDiscountCurrent`	$5.73K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$2.07M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$2.35M	USD	Point-in-time
Goodwill	`Goodwill`	$1.62M	USD	Point-in-time
Goodwill	`Goodwill`	$1.62M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$216.44K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$221.99K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$19.57M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$16.78M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$7.82M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$4.57M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$2.67M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$1.78M	USD	Point-in-time
Note payable, net of debt discount of $5,733	`NotesPayableCurrent`	$394.27K	USD	Point-in-time
Note payable, net of debt discount of $5,733	`NotesPayableCurrent`	-	USD	Point-in-time
Lines of credit	`NotesAndLinesOfCreditPayableCurrent`	$188.76K	USD	Point-in-time
Lines of credit	`NotesAndLinesOfCreditPayableCurrent`	$234.26K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$10.23M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$7.43M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.81M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	-	USD	Point-in-time
Deferred rent liability	`DeferredRentCreditNoncurrent`	$814.35K	USD	Point-in-time
Deferred rent liability	`DeferredRentCreditNoncurrent`	$728.88K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$43.48K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$43.48K	USD	Point-in-time
Total liabilities	`Liabilities`	$11.09M	USD	Point-in-time
Total liabilities	`Liabilities`	$11.02M	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES AND SUBSEQUENT EVENTS	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES AND SUBSEQUENT EVENTS	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series A Preferred stock, par value $0.001; 5,000,000 shares authorized (inclusive of Series B); 1,111,111 issued and outstanding	`TemporaryEquityCarryingAmountAttributableToParent`	$7.08M	USD	Point-in-time
Common Stock, par value $0.001; 100,000,000 shares authorized, 6,033,518 and 5,876,852 shares issued and outstanding as of December 31, 2016 and March 31, 2016, respectively	`CommonStockValue`	$6.03K	USD	Point-in-time
Common Stock, par value $0.001; 100,000,000 shares authorized, 6,033,518 and 5,876,852 shares issued and outstanding as of December 31, 2016 and March 31, 2016, respectively	`CommonStockValue`	$5.88K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$25.91M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$23.52M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-33.09M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-28.68M	USD	Point-in-time
Stockholders' equity (deficit) attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$3.79M	USD	Point-in-time
Stockholders' equity (deficit) attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-1.27M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$2.74M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$1.91M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.47M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.70M	USD	Point-in-time
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$16.78M	USD	Point-in-time
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$19.57M	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`Revenues`	$10.66M	USD	1 Quarter
Net revenues	`Revenues`	$42.67M	USD	3 Qtrs
Net revenues	`Revenues`	$32.23M	USD	3 Qtrs
Net revenues	`Revenues`	$15.67M	USD	1 Quarter
Cost of services	`CostOfServices`	$8.46M	USD	1 Quarter
Cost of services	`CostOfServices`	$24.30M	USD	3 Qtrs
Cost of services	`CostOfServices`	$35.02M	USD	3 Qtrs
Cost of services	`CostOfServices`	$12.72M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.49M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.51M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$11.19M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$12.78M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$287.03K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$148.93K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$145.59K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$484.15K	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$48.28M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$35.77M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$12.12M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$17.35M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.61M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.68M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.46M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.54M	USD	3 Qtrs
Interest expense	`InterestExpense`	$530.20K	USD	3 Qtrs
Interest expense	`InterestExpense`	$100.98K	USD	1 Quarter
Interest expense	`InterestExpense`	$15.71K	USD	3 Qtrs
Interest expense	`InterestExpense`	$9.99K	USD	1 Quarter
Change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$1.63M	USD	3 Qtrs
Change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$430.40K	USD	1 Quarter
Change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$300.00K	USD	1 Quarter
Change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$313.53K	USD	3 Qtrs
Loss on debt extinguishment	`ExtinguishmentOfDebtGainLossNetOfTax`	$-266.36K	USD	1 Quarter
Loss on debt extinguishment	`ExtinguishmentOfDebtGainLossNetOfTax`	$-266.36K	USD	3 Qtrs
Loss on debt extinguishment	`ExtinguishmentOfDebtGainLossNetOfTax`	-	USD	1 Quarter
Loss on debt extinguishment	`ExtinguishmentOfDebtGainLossNetOfTax`	-	USD	3 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$13.42K	USD	3 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$888.00	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-100.34K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-94.43K	USD	3 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$-577.47K	USD	3 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$1.63M	USD	3 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$-37.30K	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$290.89K	USD	1 Quarter
Loss before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.50M	USD	1 Quarter
Loss before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.98M	USD	3 Qtrs
Loss before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.38M	USD	1 Quarter
Loss before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-4.11M	USD	3 Qtrs
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$99.52K	USD	1 Quarter
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-127.08K	USD	3 Qtrs
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$36.20K	USD	1 Quarter
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-57.25K	USD	3 Qtrs
Net loss	`ProfitLoss`	$-4.06M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-1.53M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.85M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-1.48M	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$152.65K	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$642.05K	USD	3 Qtrs
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$551.76K	USD	3 Qtrs
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$248.23K	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.69M	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-4.70M	USD	3 Qtrs
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-4.41M	USD	3 Qtrs
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.73M	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.31	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.74	USD	3 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.93	USD	3 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.29	USD	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	5.03M	shares	3 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	5.37M	shares	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	5.99M	shares	3 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.03M	shares	1 Quarter

Cash Flow Statement 105 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-4.06M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-1.53M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.85M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-1.48M	USD	1 Quarter
Provision for doubtful accounts, net of recoveries	`ProvisionForDoubtfulAccounts`	$160.63K	USD	3 Qtrs
Provision for doubtful accounts, net of recoveries	`ProvisionForDoubtfulAccounts`	$196.00K	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-6.94K	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$287.03K	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$148.93K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$145.59K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$484.15K	USD	3 Qtrs
Deferred income tax	`DeferredIncomeTaxExpenseBenefit`	$9.19K	USD	3 Qtrs
Deferred income tax	`DeferredIncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$844.27K	USD	3 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$26.51K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$179.29K	USD	3 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$350.51K	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-266.36K	USD	3 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Amortization of deferred financing costs	`AdjustmentForAmortization`	$37.93K	USD	3 Qtrs
Amortization of deferred financing costs	`AdjustmentForAmortization`	$77.79K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$1.15K	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$1.15K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$-42.04K	USD	3 Qtrs
Change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$1.63M	USD	3 Qtrs
Change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$430.40K	USD	1 Quarter
Change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$300.00K	USD	1 Quarter
Change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$313.53K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.75M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$49.12K	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-267.71K	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-96.25K	USD	3 Qtrs
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$-16.34K	USD	3 Qtrs
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$-2.19K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$71.16K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$205.32K	USD	3 Qtrs
Deferred financing costs	`IncreaseDecreaseInDeferredCharges`	$-517.13K	USD	3 Qtrs
Deferred financing costs	`IncreaseDecreaseInDeferredCharges`	-	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$5.54K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$930.00	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$3.25M	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$371.91K	USD	3 Qtrs
Deferred rent liability	`IncreaseDecreaseInOtherDeferredLiability`	$85.47K	USD	3 Qtrs
Deferred rent liability	`IncreaseDecreaseInOtherDeferredLiability`	$9.37K	USD	3 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-889.50K	USD	3 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$678.63K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-4.20M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-1.83M	USD	3 Qtrs
Restricted cash	`IncreaseDecreaseInRestrictedCash`	$235.00K	USD	3 Qtrs
Restricted cash	`IncreaseDecreaseInRestrictedCash`	-	USD	3 Qtrs
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$165.98K	USD	3 Qtrs
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$259.55K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-165.98K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-494.55K	USD	3 Qtrs
Proceeds from issuance of preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$10.00M	USD	3 Qtrs
Proceeds from issuance of preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	-	USD	3 Qtrs
Proceeds from lines of credit	`ProceedsFromLinesOfCredit`	$145.50K	USD	3 Qtrs
Proceeds from lines of credit	`ProceedsFromLinesOfCredit`	-	USD	3 Qtrs
Principal payments on lines of credit	`RepaymentsOfNotesPayable`	$1.00M	USD	3 Qtrs
Principal payments on lines of credit	`RepaymentsOfNotesPayable`	$100.00K	USD	3 Qtrs
Proceeds from note payable	`ProceedsFromNotesPayable`	$400.00K	USD	3 Qtrs
Proceeds from note payable	`ProceedsFromNotesPayable`	-	USD	3 Qtrs
Principal payments on note payable	`PrincipalPaymentsOnTermNotePayable`	-	USD	3 Qtrs
Principal payments on note payable	`PrincipalPaymentsOnTermNotePayable`	$6.53M	USD	3 Qtrs
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	$1.20M	USD	3 Qtrs
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	$595.42K	USD	3 Qtrs
Repurchase of equity interests	`PaymentsForRepurchaseOfEquity`	-	USD	3 Qtrs
Repurchase of equity interests	`PaymentsForRepurchaseOfEquity`	$251.85K	USD	3 Qtrs
Proceeds from the exercise of warrants	`ProceedsFromWarrantExercises`	$172.00K	USD	3 Qtrs
Proceeds from the exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	3 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.63M	USD	3 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-582.50K	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-369.52K	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-5.28M	USD	3 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$9.27M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.64M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.99M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.01M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$9.27M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.64M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.99M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.01M	USD	Point-in-time
Interest paid	`InterestPaid`	$499.01K	USD	3 Qtrs
Interest paid	`InterestPaid`	$13.13K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$93.95K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$13.70K	USD	3 Qtrs
Warrant liability issued in connection with preferred stock	`ConversionOfStockAmountIssued1`	-	USD	3 Qtrs
Warrant liability issued in connection with preferred stock	`ConversionOfStockAmountIssued1`	$2.92M	USD	3 Qtrs
Issuance of common stock on conversion of warrants	`StockIssued1`	-	USD	3 Qtrs
Issuance of common stock on conversion of warrants	`StockIssued1`	$1.66M	USD	3 Qtrs
Issuance of common stock on conversion of convertible note	`DebtConversionConvertedInstrumentAmount1`	$1.40M	USD	3 Qtrs
Issuance of common stock on conversion of convertible note	`DebtConversionConvertedInstrumentAmount1`	-	USD	3 Qtrs
Tenant improvement allowance	`TenantImprovementAllowance`	$659.36K	USD	3 Qtrs
Tenant improvement allowance	`TenantImprovementAllowance`	-	USD	3 Qtrs
Change in non-controlling interest ownership	`IncreaseDecreaseInNoncontrollingInterestOwnership`	-	USD	3 Qtrs
Change in non-controlling interest ownership	`IncreaseDecreaseInNoncontrollingInterestOwnership`	$338.03K	USD	3 Qtrs
Reclassification of derivative liability to equity	`ReclassificationOfDerivativeLiabilityToEquity`	-	USD	3 Qtrs
Reclassification of derivative liability to equity	`ReclassificationOfDerivativeLiabilityToEquity`	$1.18M	USD	3 Qtrs
Reclassification of mezzanine equity to permanent equity	`ReclassificationOfMezzanineEquityToPermanentEquity`	-	USD	3 Qtrs
Reclassification of mezzanine equity to permanent equity	`ReclassificationOfMezzanineEquityToPermanentEquity`	$7.08M	USD	3 Qtrs
Release of non-controlling interest due to acquisition of BAHA	`ReleaseOfNoncontrollingInterestDueToAcquisitionOfBaha`	$183.41K	USD	3 Qtrs
Release of non-controlling interest due to acquisition of BAHA	`ReleaseOfNoncontrollingInterestDueToAcquisitionOfBaha`	-	USD	3 Qtrs
Relative fair value of warrant included in debt discount	`FairValueOfWarrantIncludedInDebtDiscount`	$6.88K	USD	3 Qtrs
Relative fair value of warrant included in debt discount	`FairValueOfWarrantIncludedInDebtDiscount`	-	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.